Ingrid Haugen

High Potent Containment Provider ONFAB Enters USA Market

2 min read

High Potent Containment Provider ONFAB Enters USA Market

ONFAB, a leading European provider of single-use, flexible containment solutions for the pharmaceutical industry, has officially launched...

Read More

Gedeon Richter: Cariprazine Proves Effective in Treating Dual Diagnosis

2 min read

Gedeon Richter: Cariprazine Proves Effective in Treating Dual Diagnosis

New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of the European...

Read More

From U.S. To South Korea: NuBest® Nutrition Expands Global Reach Through Online Retailer Coupang

2 min read

From U.S. To South Korea: NuBest® Nutrition Expands Global Reach Through Online Retailer Coupang

NuBest® Nutrition proudly announces its global expansion into South Korea through a strategic partnership with Coupang Co.,...

Read More

Health Carousel Nurse Honored with CGFNS DAISY Award for Outstanding International Nurse Recruiter

2 min read

Health Carousel Nurse Honored with CGFNS DAISY Award for Outstanding International Nurse Recruiter

Health Carousel is proud to announce that our very own Nurse Manager, Christy Craft, has been honored with...

Read More

Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder

1 min read

Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2...

Read More

Landmark Non-inferiority Clinical Trial Demonstrates Nanodropper’s Positive Impact on Glaucoma Treatment

2 min read

Landmark Non-inferiority Clinical Trial Demonstrates Nanodropper’s Positive Impact on Glaucoma Treatment

Nanodropper, Inc., an ophthalmic device company that created the eyedrop volume-reducing Nanodropper® Adaptor, announced today that its clinical trial...

Read More

Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis

2 min read

Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH), today...

Read More

FRC, Dr. Michael New Unveil Initial Findings in Joint Study on Perinatal Hospice

2 min read

FRC, Dr. Michael New Unveil Initial Findings in Joint Study on Perinatal Hospice

Today, Family Research Council (FRC), together with Dr. Michael New, Assistant Professor of Social Research at the Busch...

Read More

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

2 min read

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro...

Read More

Treatment Options to Help Overcome Knee Pain for Sports Enthusiasts

2 min read

Treatment Options to Help Overcome Knee Pain for Sports Enthusiasts

(Family Features) Millions of people experience chronic pain, with knee pain among the most common. Athletes and active adults...

Read More